CiteULike: guhjy's cancer [more than 800 articles]

	The role of Mediterranean type of diet on the development of cancer and cardiovascular disease, in the elderly: A systematic review. [My Copy] Maturitas (3 August 2009) by Stefanos Tyrovolas, Demosthenes B. Panagiotakos posted to mediterranean diet cv cancer by guhjy on 2009-11-20 02:37:45 as
	The role of metallothionein in oncogenesis and cancer prognosis [My Copy] Progress in Histochemistry and Cytochemistry, Vol. 44, No. 1. (22 April 2009), pp. 29-64. by Mie Pedersen, Agnete Larsen, Meredin Stoltenberg, Milena Penkowa posted to metallotheionein cancer by guhjy on 2009-11-17 09:39:16 as
	Multitargeted therapy of cancer by silymarin [My Copy] Cancer Letters, Vol. 269, No. 2. (08 October 2008), pp. 352-362. by K. Ramasamy, R. Agarwal posted to silymarin cancer by guhjy on 2009-11-17 09:38:14 as
	Signal integration by JNK and p38 MAPK pathways in cancer development. [My Copy] Nature reviews. Cancer, Vol. 9, No. 8. (August 2009), pp. 537-549. by Erwin F. Wagner, Angel R. Nebreda posted to p38 jnk cancer by guhjy on 2009-11-17 09:32:13 as along with 3 people chica tonamswish renatomilani
	The ubiquitin pathway: An emerging drug target in cancer therapy. [My Copy] European journal of pharmacology (14 October 2009) by Sudharsana Rao R. Ande, Junjie Chen, Subbareddy Maddika posted to ub cancer by guhjy on 2009-11-17 04:16:56 as
	Transforming growth factor-beta during carcinogenesis: the shift from epithelial to mesenchymal signaling. [My Copy] Journal of gastroenterology, Vol. 41, No. 4. (April 2006), pp. 295-303. by Koichi Matsuzaki, Kazuichi Okazaki posted to tgfb emt cancer by guhjy on 2009-11-17 02:32:43 as
	Cyclooxygenase-2 (COX-2)--a therapeutic target in liver cancer? [My Copy] Current pharmaceutical design, Vol. 13, No. 32. (2007), pp. 3305-3315. by Marco Breinig, Peter Schirmacher, Michael André A. Kern posted to cox2 cancer by guhjy on 2009-11-17 02:29:45 as
	The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway. [My Copy] Oncogene, Vol. 27, No. 48. (20 October 2008), pp. 6207-6215. by S. Wang posted to trail tnf cancer apoptosis by guhjy on 2009-11-17 02:18:49 as
	TRAIL as a target in anti-cancer therapy. [My Copy] Cancer letters, Vol. 285, No. 1. (18 November 2009), pp. 1-5. by Gen Sheng S. Wu posted to trail cancer by guhjy on 2009-11-17 02:17:39 as
	Systematic review: primary and secondary prevention of gastrointestinal cancers with antioxidant supplements. [My Copy] Alimentary pharmacology & therapeutics, Vol. 28, No. 6. (15 September 2008), pp. 689-703. by G. Bjelakovic, D. Nikolova, R. G. Simonetti, C. Gluud posted to meta-analysis cancer antioxidant by guhjy on 2009-11-15 10:06:27 as
	Tissue microarrays as a tool in the discovery and validation of tumor markers. [My Copy] Methods in molecular biology (Clifton, N.J.), Vol. 520 (2009), pp. 151-161. by Stephen M. Hewitt posted to tma cancer by guhjy on 2009-11-15 02:47:52 as
	Pharmacogenetics and pharmacogenomics of anticancer agents. [My Copy] CA: a cancer journal for clinicians, Vol. 59, No. 1. (1 January 2009), pp. 42-55. by R. Stephanie Huang, Mark J. Ratain posted to pharmacogenetics cancer by guhjy on 2009-11-15 02:45:32 as along with 1 person songpku
	Commentary: Antioxidants for cancer: new tricks for an old dog? [My Copy] The oncologist, Vol. 14, No. 3. (March 2009), pp. 213-215. by Nima Sharifi posted to ros cancer by guhjy on 2009-11-14 16:49:36 as
	Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. [My Copy] Proceedings of the Japan Academy. Series B, Physical and biological sciences, Vol. 85, No. 8. (2009), pp. 314-323. by Kohei Miyazono posted to tgfb emt cancer by guhjy on 2009-11-14 04:38:44 as along with 2 people NicolSiegel aarongardner85
	Tubers and tumors: rapamycin therapy for benign and malignant tumors. [My Copy] Current opinion in cell biology, Vol. 21, No. 2. (April 2009), pp. 230-236. by David R. Plas, George Thomas posted to rapamycin cancer by guhjy on 2009-11-13 04:19:15 as
	Optimal targeting of the mTORC1 kinase in human cancer. [My Copy] Current opinion in cell biology, Vol. 21, No. 2. (April 2009), pp. 219-229. by Heidi A. Lane, Madlaina Breuleux posted to mtorc1 mtor inhibitor cancer by guhjy on 2009-11-13 02:14:36 as
	Targeting the EGFR and the PKB pathway in cancer. [My Copy] Current opinion in cell biology, Vol. 21, No. 2. (April 2009), pp. 185-193. by Shoshana Klein, Alexander Levitzki posted to inhibitor egfr cancer akt by guhjy on 2009-11-13 02:13:33 as
	Current status and challenges associated with targeting mTOR for cancer therapy. [My Copy] BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, Vol. 23, No. 2. (2009), pp. 77-91. by Ryan J. Dowling, Michael Pollak, Nahum Sonenberg posted to mtor inhibitor cancer by guhjy on 2009-11-13 02:13:07 as
	Factors underlying sensitivity of cancers to small-molecule kinase inhibitors. [My Copy] Nature reviews. Drug discovery, Vol. 8, No. 9. (24 September 2009), pp. 709-723. by Pasi A. Jänne, Nathanael Gray, Jeff Settleman posted to kinase inhibitor cancer by guhjy on 2009-11-13 02:00:24 as along with 3 people kokphinchooi TimRooney renatomilani
	Molecular targeted therapies for solid tumors: management of side effects. [My Copy] Onkologie, Vol. 32, No. 3. (March 2009), pp. 129-138. by Viktor Grünwald, Jens Soltau, Philipp Ivanyi, Jochen Rentschler, Christoph Reuter, Joachim Drevs posted to targeted-therapy cancer by guhjy on 2009-11-13 01:57:39 as
	mTORbeta splicing isoform promotes cell proliferation and tumorigenesis. [My Copy] The Journal of biological chemistry, Vol. 284, No. 45. (6 November 2009), pp. 30807-30814. by Ganna Panasyuk, Ivan Nemazanyy, Aleksander Zhyvoloup, et al.Valeriy Filonenko, Derek Davies, Mathew Robson, R. Barbara Pedley, Michael Waterfield, Ivan Gout posted to mtor cancer by guhjy on 2009-11-12 09:39:05 as
	Targeting the mTOR signaling network for cancer therapy. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, No. 13. (1 May 2009), pp. 2278-2287. by Funda Meric-Bernstam, Ana Maria M. Gonzalez-Angulo posted to mtor cancer by guhjy on 2009-11-12 06:39:49 as along with 1 person NicolSiegel
	Targeting mTOR globally in cancer: Thinking beyond rapamycin. [My Copy] Cell cycle (Georgetown, Tex.), Vol. 8, No. 23. (14 December 2009) by Boris Shor, James J. Gibbons, Robert T. Abraham, Ker Yu posted to rapamycin mtorc2 mtor inhibitor cancer by guhjy on 2009-11-12 06:31:26 as
	Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells. [My Copy] Biochimica et biophysica acta, Vol. 1791, No. 9. (02 September 2009), pp. 949-955. by David A. Foster posted to pld phosphatidic-acid mtor cancer by guhjy on 2009-11-12 05:04:05 as
	Targeting mTOR with rapamycin: one dose does not fit all. [My Copy] Cell cycle (Georgetown, Tex.), Vol. 8, No. 7. (1 April 2009), pp. 1026-1029. by David A. Foster, Alfredo Toschi posted to rapamycin phosphatidic-acid mtorc2 mtorc1 mtor inhibitor cancer by guhjy on 2009-11-12 05:01:33 as
	S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation. [My Copy] The Journal of biological chemistry, Vol. 284, No. 10. (6 March 2009), pp. 6361-6369. by Rachel L. Yamnik, Alla Digilova, Daphne C. Davis, Z. Nilly Brodt, Christopher J. Murphy, Marina K. Holz posted to rsk proliferation era cancer by guhjy on 2009-11-11 06:16:14 as
	HIF2Î± inhibition promotes p53 pathway activity, tumor cell death, and radiation responses [My Copy] Proceedings of the National Academy of Sciences, Vol. 106, No. 34. (25 August 2009), pp. 14391-14396. by Jessica A. Bertout, Amar J. Majmundar, John D. Gordan, et al.Jennifer C. Lam, Dara Ditsworth, Brian Keith, Eric J. Brown, Katherine L. Nathanson, M. Celeste Simon posted to p53 hif2 hif cancer by guhjy on 2009-11-10 04:13:19 as
	Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis. [My Copy] Advanced drug delivery reviews, Vol. 61, No. 4. (28 April 2009), pp. 319-326. by Makiya Nishikawa, Mitsuru Hashida, Yoshinobu Takakura posted to ros catalase cancer by guhjy on 2009-11-10 02:43:44 as
	Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy. [My Copy] Cell cycle (Georgetown, Tex.), Vol. 8, No. 4. (15 February 2009), pp. 567-572. by Andrew Y. Choo, John Blenis posted to mtor cancer by guhjy on 2009-11-10 01:48:21 as
	Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. [My Copy] The Journal of biological chemistry, Vol. 282, No. 45. (9 November 2007), pp. 32582-32590. by Bin Shi, Laura Sepp-Lorenzino, Marco Prisco, Peter Linsley, Tiziana deAngelis, Renato Baserga posted to mirna mir145 irs1 growth cancer by guhjy on 2009-11-10 01:40:41 as
	IRS1 Regulation by Wnt/beta-catenin Signaling and Varied Contribution of IRS1 to the Neoplastic Phenotype. [My Copy] The Journal of biological chemistry (20 October 2009) by Guido T. Bommer, Ying Feng, Ayaka Iura, et al.Thomas J. Giordano, Rork Kuick, Huseyin Kadikoy, Deanna Sikorski, Rong Wu, Kathleen R. Cho, Eric R. Fearon posted to wnt irs1 catenin cancer by guhjy on 2009-11-09 05:17:07 as
	Biomarkers in population studies: environmental mutagenesis and risk for cancer. [My Copy] Reviews on environmental health, Vol. 24, No. 2. (n 2009), pp. 117-127. by William W. Au, Mathuros Ruchirawat posted to environment cancer biomarker by guhjy on 2009-11-09 05:13:26 as
	DNA oxidation: investigating its key role in environmental mutagenesis with the comet assay. [My Copy] Mutation research, Vol. 674, No. 1-2. (31 March 2009), pp. 101-108. by Amaya Azqueta, Sergey Shaposhnikov, Andrew R. Collins posted to ros environment dna comet cancer by guhjy on 2009-11-09 05:13:13 as
	The emerging epidemic of environmental cancers in developing countries. [My Copy] Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 20, No. 2. (February 2009), pp. 205-212. by P. Vineis, W. Xun posted to environment cancer by guhjy on 2009-11-09 05:12:28 as
	No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis [My Copy] Diabetologia, Vol. 52, No. 12. (1 December 2009), pp. 2507-2512. by A. Dejgaard, H. Lynggaard, J. Råstam, M. Krogsgaard Thomsen posted to insulin cancer by guhjy on 2009-11-04 06:06:55 as along with 1 person booker
	The Biphasic Role of the Hypoxia-Inducible Factor Prolyl-4-Hydroxylase, PHD2, in Modulating Tumor-Forming Potential [My Copy] Molecular Cancer Research, Vol. 6, No. 5. (May 2008), pp. 829-842. by KangAe Lee, Jeremy D. Lynd, Sandra O'Reilly, Matti Kiupel, Justin J. McCormick, John J. LaPres posted to phd hif cancer by guhjy on 2009-10-29 06:35:32 as
	Prolyl Hydroxylase-3 Is Downregulated in Colorectal Cancer Cells and Inhibits IKKbeta, Independent of Hydroxylase Activity. [My Copy] Gastroenterology (25 September 2009) by Jing Xue, Xuebing Li, Shi Jiao, Ye Wei, Guohao Wu, Jing Fang posted to phd nfkb ikk cancer by guhjy on 2009-10-29 06:15:01 as
	Inhibiting the hypoxia response for cancer therapy: the new kid on the block. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, No. 19. (1 October 2009), pp. 5945-5946. by Mei Yee Y. Koh, Taly R. Spivak-Kroizman, Garth Powis posted to hypoxia hif cancer by guhjy on 2009-10-29 06:14:10 as
	Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth. [My Copy] Biochimica et biophysica acta, Vol. 1793, No. 2. (February 2009), pp. 368-377. by Lavinia Nardinocchi, Rosa Puca, Diego Guidolin, et al.Anna S. Belloni, Gianluca Bossi, Carine Michiels, Ada Sacchi, Maurizio Onisto, Gabriella D'Orazi posted to hif cancer by guhjy on 2009-10-29 06:14:00 as
	Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha. [My Copy] PloS one, Vol. 4, No. 8. (2009) by Lavinia Nardinocchi, Rosa Puca, Ada Sacchi, Gideon Rechavi, David Givol, Gabriella D'Orazi posted to phd p53 hypoxia cancer by guhjy on 2009-10-29 06:13:44 as
	An essential role of the HIF-1alpha-c-Myc axis in malignant progression. [My Copy] Annals of the New York Academy of Sciences, Vol. 1177 (October 2009), pp. 198-204. by Young-Gun G. Yoo, Masami Hayashi, Jared Christensen, L. Eric Huang posted to myc hif cancer by guhjy on 2009-10-29 05:56:59 as
	Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition. [My Copy] Cancer research, Vol. 69, No. 6. (15 March 2009), pp. 2638-2646. by Marzia Scortegagna, Rebecca J. Martin, Raleigh D. Kladney, Robert G. Neumann, Jeffrey M. Arbeit posted to hif emt cancer by guhjy on 2009-10-29 05:45:09 as
	The Double-Edged Sword of Autophagy Modulation in Cancer [My Copy] Clinical Cancer Research, Vol. 15, No. 17. (1 September 2009), pp. 5308-5316. by Eileen White, Robert S. DiPaola posted to cancer autophagy by guhjy on 2009-10-29 05:26:22 as
	Harnessing the hypoxia-inducible factor in cancer and ischemic disease [My Copy] Biochemical Pharmacology, Vol. 73, No. 3. (01 February 2007), pp. 450-457. by M. Brahimihorn, J. Pouyssegur posted to hif cancer by guhjy on 2009-10-29 05:19:41 as
	Mitochondrial gateways to cancer [My Copy] Molecular Aspects of Medicine (19 August 2009) by Lorenzo Galluzzi, Eugenia Morselli, Oliver Kepp, et al.Ilio Vitale, Alice Rigoni, Erika Vacchelli, Mickael Michaud, Hans Zischka, Maria Castedo, Guido Kroemer posted to mt cancer by guhjy on 2009-10-29 05:08:39 as
	HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. [My Copy] Mini reviews in medicinal chemistry, Vol. 9, No. 9. (August 2009), pp. 1084-1101. by Alvaro Marín-Hernández, Juan C. Gallardo-Pérez, Stephen J. Ralph, Sara Rodríguez-Enríquez, Rafael Moreno-Sánchez posted to hif cancer by guhjy on 2009-10-29 05:01:26 as
	Hypoxia-inducible factors: central regulators of the tumor phenotype [My Copy] Current Opinion in Genetics & Development, Vol. 17, No. 1. (February 2007), pp. 71-77. by J. Gordan, M. Simon posted to hif cancer by guhjy on 2009-10-29 04:43:01 as
	Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. [My Copy] Gastroenterology, Vol. 137, No. 5. (November 2009) by Chun-Ying Y. Wu, Ken N. Kuo, Ming-Shiang S. Wu, Yi-Ju J. Chen, Chang-Bi B. Wang, Jaw-Town T. Lin posted to tw pud nhi hp cancer by guhjy on 2009-10-29 04:17:05 as
	Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. [My Copy] Applied physiology, nutrition, and metabolism = Physiologie appliquée, nutrition et métabolisme, Vol. 33, No. 6. (December 2008), pp. 1269-1283. by Rob M. van Dam posted to dm cv coffee cancer by guhjy on 2009-10-29 01:51:14 as
	Diet, gender, and colorectal neoplasia. [My Copy] Journal of clinical gastroenterology, Vol. 41, No. 8. (September 2007), pp. 731-746. by Elizabeth T. Jacobs, Patricia A. Thompson, María Elena E. Martínez posted to gender diet cancer by guhjy on 2009-10-21 03:16:03 as

guhjy's cancer [more than 800 articles] Export

guhjy's tags